Prospective Huntington At Risk Observational Study

CompletedOBSERVATIONAL
Enrollment

1,001

Participants

Timeline

Start Date

July 9, 1999

Primary Completion Date

December 17, 2009

Study Completion Date

December 17, 2009

Conditions
Huntington Disease
Trial Locations (42)

Unknown

University of Alabama, Birmingham

Mayo Clinic Arizona, Phoenix

University of California at San Diego, La Jolla

UCLA School of Medicine, Los Angeles

University of California, Davis, Sacramento

Colorado Neurological Institute, Englewood

University of Connecticut, Hartford

Institute for Neurodegenerative Disorders, New Haven

University of Miami School of Medicine, Miami

University of South Florida, Tampa

Emory University, Atlanta

Rush University Medical Center, Chicago

Indiana University School of Medicine, Indianapolis

University of Iowa, Iowa City

University of Kansas Medical Center, Kansas City

Hereditary Neurological Disease Center, Wichita

Johns Hopkins University, Baltimore

University of Maryland at Baltimore, Baltimore

Boston University School of Medicine, Boston

Massachusetts General Hospital, Boston

University of Michigan, Ann Arbor

Hennepin County Medical Center, Minneapolis

Washington University School of Medicine, St Louis

UMDNJ Huntington Disease Service Center, Stratford

Albany Medical College, Albany

North Shore-LIJ Health System, Manhasset

Columbia University, New York

University of Rochester, Rochester

Wake Forest University Baptist Medical Center, Winston-Salem

Ohio State University, Columbus

Oregon Health and Science University, Portland

University of Pennsylvania, Philadelphia

NeuroHealth Parkinson's Disease Movement Disorders Center, Pawtucket

Baylor College of Medicine, Houston

University of Virginia, Charlottesville

University of Washington and VA Puget Sound, Seattle

Medical College of Wisconsin-Milwaukee, Milwaukee

University of Calgary, Calgary

University of Alberta, Edmonton

University of British Columbia, Vancouver

The Centre for Addiction and Mental Health, Markham

Hotel-Dieu Hospital-CHUM, Montreal

All Listed Sponsors
collaborator

National Human Genome Research Institute (NHGRI)

NIH

collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

Huntington Study Group

NETWORK

NCT00052143 - Prospective Huntington At Risk Observational Study | Biotech Hunter | Biotech Hunter